Stay updated on Immunotherapy Combination Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy Combination Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy Combination Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.3%
    Check dated 2025-06-21T00:07:06.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about clinical trials for prostate cancer treatments, specifically mentioning the National Cancer Institute and key drugs like Bavarian-Nordic (BN)-brachyury and bintrafusp alfa (M7824). Additionally, the results reporting date has been updated to June 8, 2025.
    Difference
    70%
    Check dated 2025-06-13T16:50:45.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-06T11:38:37.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.8%
    Check dated 2025-05-29T05:52:09.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T13:58:05.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new version of a clinical study on metastatic prostate cancer, including the addition of a new drug, Epacadostat, and a change in the study's revision number from v2.14.4 to v2.15.0. Additionally, the previous background information on immunotherapy has been removed.
    Difference
    59%
    Check dated 2025-04-16T02:14:01.000Z thumbnail image

Stay in the know with updates to Immunotherapy Combination Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combination Clinical Trial page.